Blog | Curebase

How DCT Technology Can Enable Follow-up Clinical Studies

May 12, 2023

The benefits of flexible and decentralized LTFU studies

The benefits of DCT components in small drug trials

May 4, 2023

How implementing specific decentralized components can directly address challenges in small pharma trials.

How DCTs impact dermatology drug research

April 27, 2023

Learn why dermatology drug trials are well suited to incorporate decentralized components and tech for study optimization.

How DCTs optimize sample collection for in vitro diagnostic studies

April 20, 2023

In vitro diagnostic studies are ideal for decentralized trial models where patients are able to participate without having to travel to research centers and can give samples from the comfort of their own homes.

Curebase welcomes
Adam Samson as director of clinical operations

June 18, 2020

At Curebase we are rapidly expanding and preparing for the wave of decentralization in clinical trials that we intend to lead. To that end we have recently hired a Director of Clinical Operations, Adam Samson...

Curebase welcomes
Adam Samson as director of clinical operations

June 18, 2020

548 Market St

PMB 86319

San Francisco, CA 94104-5401

United States

hello@curebase.com

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Terms & Conditions

Privacy

Privacy(Spanish)

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

548 Market St
PMB 86319
San Francisco, CA 94104-5401
United States

Find us on social

Subscribe to Curebase content